Why the study?
Does intravenous infusion of endothelin-1 alter pulmonary and renal hemodynamics and ET-1 clearance differently in young smokers compared to non-smokers?
Does intravenous infusion of endothelin-1 alter pulmonary and renal hemodynamics and ET-1 clearance differently in young smokers compared to non-smokers?
Young smokers exhibit increased plasma clearance and pulmonary elimination of endothelin-1, alongside more pronounced renal vasoconstriction, compared to non-smokers.
Answers are grounded in this paper and cite their sources.
ET-1 may induce greater renal vasoconstriction in young smokers; leaves open its contribution to smoking-related vascular risk.
Pulmonary and renal haemodynamics and elimination of endothelin-1 (ET-1) were studied in six young smokers in response to 20 min intravenous infusion of ET-1 (4 pmol kg(-1) min(-1)) after smoking. At 20 min of ET-1 infusion fractional ET-1 extractions in the lungs and kidneys were 60 +/- 2 and 60 +/- 7%, respectively. Cardiac output and renal blood flow (RBF) fell by 18 +/- 4% (P<0.05) and 34 +/- 5% (P<0.01). Mean systemic arterial pressure increased (P<0.05) whereas pulmonary pressures were unchanged. Compared with previously published data in non-smokers (Weitzberg et al., 1991, 1993) basal arterial ET-1 and ET-1-values during ET-1 infusion were lower with a more rapid return to basal value. Smokers had higher pulmonary extraction of ET-1 at the same pulmonary arterial concentration (P<0.05). RBF reduction was more pronounced (P<0.05). Systemic vascular resistance increased while pulmonary vascular resistance did not increase as in non-smokers. Increased plasma clearance and more efficient pulmonary elimination of ET-1 lowers the arterial level in young smokers. In addition ET-1 evokes more pronounced renal vasoconstriction in these individuals.
No takes yet. Share an insight, caveat, or question.
Ahlborg et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: